FDA Inspection
LifeShare Blood CenterLifeShare Blood Center – FDA Inspection, May 25, 2017
Record Details
This FDA Inspection record concerns LifeShare Blood Center, with an inspection on May 25, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · bef4675f-8b81-46c4-9c56-69958dd7eac4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1011812
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LifeShare Blood Center
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 14, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 13, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 27, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 6, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 19, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for LifeShare Blood Center
- FDA Inspection 1181230 - 2022-09-14
- FDA Inspection 1095940 - 2018-12-13
- FDA Inspection 916535 - 2015-02-27
- FDA Inspection 838706 - 2013-05-06
- FDA Inspection 679798 - 2010-08-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.